Subtype
Malignant Uterine Neoplasm
CI-CAN-00005955Explore in graph →
824 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005955Explore in graph →
Clinical trials
3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (333)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00030485 | Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jan 27, 2014 | clinicaltrials |
| NCT00085332 | Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 5 | Jan 13, 2014 | clinicaltrials |
| NCT00003065 | Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix | completed | Phase 2 | 25 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003560 | Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | unknown | Phase 2 | 40 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003718 | Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma | unknown | Phase 2 | 25 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT01999933 | Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer | unknown | Phase 2 / Phase 3 | 600 | Mei ShiOTHER | 1 | Dec 3, 2013 | clinicaltrials |
| NCT01079832 | Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies | completed | Phase 2 | 50 | Case Comprehensive Cancer CenterOTHER | 1 | Nov 28, 2013 | clinicaltrials |
| NCT00138151 | Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer | terminated | Phase 2 | 33 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Nov 20, 2013 | clinicaltrials |
| NCT00023660 | Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer | completed | Phase 1 / Phase 2 | 84 | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 19, 2013 | clinicaltrials |
| NCT00072540 | S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 8, 2013 | clinicaltrials |
| NCT00002465 | High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma | unknown | Phase 1 / Phase 2 | — | St. Vincent Medical Center - Los AngelesOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01965080 | Exemestane in Advanced and Recurrent Endometrial Carcinoma | completed | Phase 2 | 52 | Nordic Society of Gynaecological Oncology - Clinical Trials UnitOTHER | 1 | Oct 18, 2013 | clinicaltrials |
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | completed | Phase 2 | 76 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 7, 2013 | clinicaltrials |
| NCT01938105 | Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer | unknown | Phase 2 | 40 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Sep 26, 2013 | clinicaltrials |
| NCT01937650 | Radiotherapy + Metronidazole vs Radiotherapy Alone In Improving Treatment Outcomes in Advanced Cervical Cancer in Uganda | completed | Phase 2 / Phase 3 | 38 | Makerere UniversityOTHER | 0 | Sep 9, 2013 | clinicaltrials |
| NCT01075399 | Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors(HX4-200) | completed | Phase 2 | 50 | Siemens Molecular ImagingINDUSTRY | 0 | Aug 30, 2013 | clinicaltrials |
| NCT00462397 | Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | unknown | Phase 2 | 50 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00632047 | Early Detection of Breast Cancer and Cervical Cancer in Women in India | unknown | Phase 2 | 151,538 | Tata Memorial HospitalOTHER_GOV | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01229930 | Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 130 | University of GlasgowOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00008112 | Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer | unknown | Phase 2 | — | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01100359 | Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer | unknown | Phase 2 | 39 | Medical University InnsbruckOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00005965 | Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix | completed | Phase 2 | — | Icahn School of Medicine at Mount SinaiOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00003445 | Docetaxel in Treating Patients With Advanced Cancer of the Cervix | completed | Phase 2 | — | Grupo Oncologico Cooperativo del SurOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00023894 | Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 5 | Jun 24, 2013 | clinicaltrials |
| NCT00026260 | SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 0 | Jun 24, 2013 | clinicaltrials |
| NCT00071929 | Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003017 | Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00005837 | Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 21, 2013 | clinicaltrials |
| NCT00005999 | Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00006005 | Thalidomide in Treating Patients With Gynecologic Sarcomas | completed | Phase 2 | — | New York University Cancer InstituteOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00002562 | Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer | completed | Phase 2 | 25 | Gynecologic Oncology GroupNETWORK | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019084 | Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019331 | Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00049556 | Gefitinib in Treating Patients With Cervical Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00278304 | Radiation Therapy in Treating Patients With Cervical Cancer | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005070 | Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Jun 19, 2013 | clinicaltrials |
| NCT00006377 | Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00002478 | Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer | terminated | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Jun 10, 2013 | clinicaltrials |
| NCT00003179 | Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer | terminated | Phase 2 | 360 | Gynecologic Oncology GroupNETWORK | 2 | Jun 10, 2013 | clinicaltrials |
| NCT00003946 | Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 10, 2013 | clinicaltrials |
| NCT00005643 | Chemotherapy in Treating Patients With Sarcoma of the Uterus | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 10, 2013 | clinicaltrials |
| NCT00005861 | Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Jun 10, 2013 | clinicaltrials |
| NCT00091130 | SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells | completed | Phase 2 | 139 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00002813 | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer | completed | Phase 2 | 62 | Gynecologic Oncology GroupNETWORK | 1 | May 27, 2013 | clinicaltrials |
| NCT00003379 | Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer | completed | Phase 1 / Phase 2 | 40 | Gynecologic Oncology GroupNETWORK | 1 | May 27, 2013 | clinicaltrials |
| NCT00005031 | Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | May 27, 2013 | clinicaltrials |
| NCT00016926 | Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | May 27, 2013 | clinicaltrials |
| NCT00276796 | Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | completed | Phase 2 | 66 | Gynecologic Oncology GroupNETWORK | 0 | May 27, 2013 | clinicaltrials |
| NCT00033358 | Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer | completed | Phase 2 | 52 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00003624 | Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer | terminated | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Apr 11, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jan 27, 2014source: clinicaltrials